[Rosemont, Illinois] December 16, 2025 - - The Society for Vascular Surgery Foundation (SVSF) Board of Directors is pleased to welcome four new board members: Rana Afifi, MD; Anahita Dua, MD.; Joe Hart, MD; and Murray Shames, MD.
Froedtert & MCW Froedtert Hospital receives national verification from the American College of Surgeons Vascular Verification Program
[Rosemont, Illinois] October 20, 2025 - The Society for Vascular Surgery (SVS) Foundation today announced the launch of the Enrico Ascher Vascular Innovation Institute, a groundbreaking initiative dedicated to advancing innovation in vascular surg
Memorial Regional Hospital receives national verification from the American College of Surgeons Vascular Verification Program
Timely update comes as September marks Peripheral Artery Disease (PAD) Awareness Month
During PAD Awareness Month, the Society for Vascular Surgery Urges Americans to Learn How to Safeguard Their Vascular Health
Rosemont, Ill. – July 17, 2025 — The Society for Vascular Surgery (SVS) acknowledges the increased public attention surrounding chronic venous insufficiency (CVI) following news reports of President Donald J.
Findings from a phase three, randomized controlled clinical trial demonstrate the superiority of Humacyte’s Acellular Tissue Engineered Vessel (ATEV) over autologous arteriovenous fistula (AVF) in high-risk patients with end-stage kidney disease (ESKD).
A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events, and inpatient admissions.